These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25080291)

  • 1. An audit of HIV care in English prisons.
    Chan SY; Marsh K; Lau R; Pakianathan M; Hughes G
    Int J STD AIDS; 2015 Jun; 26(7):504-8. PubMed ID: 25080291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. British HIV Association (BHIVA) national cohort outcomes audit of patients commencing antiretrovirals from naïve.
    Street E; Curtis H; Sabin CA; Monteiro EF; Johnson MA;
    HIV Med; 2009 Jul; 10(6):337-42. PubMed ID: 19490183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community.
    Springer SA; Pesanti E; Hodges J; Macura T; Doros G; Altice FL
    Clin Infect Dis; 2004 Jun; 38(12):1754-60. PubMed ID: 15227623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Findings from the British HIV Association's national clinical audit of first-line antiretroviral therapy and survey of treatment practice and maternity care, 2002.
    Brook MG; Curtis H; Johnson MA;
    HIV Med; 2004 Nov; 5(6):415-20. PubMed ID: 15544693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.
    Meyer JP; Cepeda J; Wu J; Trestman RL; Altice FL; Springer SA
    JAMA Intern Med; 2014 May; 174(5):721-9. PubMed ID: 24687044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Planning for success predicts virus suppressed: results of a non-controlled, observational study of factors associated with viral suppression among HIV-positive persons following jail release.
    Spaulding AC; Messina LC; Kim BI; Chung KW; Lincoln T; Teixeira P; Avery AK; Cunningham M; Stein MS; Ahuja D; Flanigan TP
    AIDS Behav; 2013 Oct; 17 Suppl 2():S203-11. PubMed ID: 23076719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A national survey of prisoners on antiretroviral therapy in Malawi: access to treatment and outcomes on therapy.
    Makombe SD; Jahn A; Tweya H; Thambo L; Yu JK; Hedt B; Weigel R; Nkhata A; Schouten EJ; Kamoto K; Harries AD
    J Infect Dev Ctries; 2007 Dec; 1(3):303-7. PubMed ID: 19734609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recall of Nadir CD4 Cell Count and Most Recent HIV Viral Load Among HIV-Infected, Socially Marginalized Adults.
    Buisker TR; Dufour MS; Myers JJ
    AIDS Behav; 2015 Nov; 19(11):2108-16. PubMed ID: 25711297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A national survey of prisoners on antiretroviral therapy in Malawi: access to treatment and outcomes on therapy.
    Makombe SD; Jahn A; Tweya H; Thambo L; Yu JK; Hedt B; Weigel R; Nkhata A; Schouten EJ; Kamoto K; Harries AD
    World Hosp Health Serv; 2008; 44(1):26-9. PubMed ID: 18549031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time taken to undetectable viral load, following the initiation of HAART.
    Currie S; Rogstad KE; Piyadigamage A; Herman S
    Int J STD AIDS; 2009 Apr; 20(4):265-6. PubMed ID: 19304973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Routine HIV Opt-Out Screening and Continuum of Care Services Following Entry into Eight Prison Reception Centers--California, 2012.
    Lucas KD; Eckert V; Behrends CN; Wheeler C; MacGowan RJ; Mohle-Boetani JC
    MMWR Morb Mortal Wkly Rep; 2016 Feb; 65(7):178-81. PubMed ID: 26914322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An audit of HIV treatment outcomes in a UK inner city cohort.
    Bird E; Cormack I; Rodgers M; Phillips D; Elgalib A
    Int J STD AIDS; 2016 Oct; 27(12):1114-1116. PubMed ID: 27147265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiretroviral therapy in 2004].
    Jablonowski H
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():46-8, 50-1. PubMed ID: 15373049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience.
    Erhabor O; Ejele OA; Nwauche CA
    Niger J Clin Pract; 2006 Dec; 9(2):128-33. PubMed ID: 17319344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment.
    Lapadula G; Cozzi-Lepri A; Marchetti G; Antinori A; Chiodera A; Nicastri E; Parruti G; Galli M; Gori A; Monforte Ad;
    AIDS; 2013 Mar; 27(5):769-79. PubMed ID: 23719349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.